Siponimod inhibits microglial inflammasome activation.

• Tác giả: Hiroshi Doi, Shunta Hashiguchi, Hiroyasu Komiya, Shun Kubota, Misako Kunii, Akihiro Ogasawara, Yuki Ogawa, Mikiko Tada, Keita Takahashi, Hideyuki Takeuchi, Fumiaki Tanaka, Kenichi Tanaka
• Ngôn ngữ: eng
• Ký hiệu phân loại: 920.71 Men
• Thông tin xuất bản: Ireland : Neuroscience research , 2025
• Bộ sưu tập: NCBI
• ID: 63639

Tóm tắt

Siponimod is the first oral drug approved for active secondary progressive multiple sclerosis. It acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptor 1 (S1P